Free radical biology of the cardiovascular system

Clinical Science

Volumn 123, Issue 2, 2012, Pages 73-91

  Chen, Alex F ^a   Chen, Dan Dan ^a   Daiber, Andreas ^b   Faraci, Frank M ^c   Li, Huige ^d   Rembold, Christopher M ^e   Laher, Ismail ^f  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^c UNIVERSITY OF IOWA   (United States)

^d JOHANNES GUTENBERG UNIVERSITY   (Germany)

^e UNIVERSITY OF VIRGINIA   (United States)

^f UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Cardiovascular disease; Endothelial progenitor cell; Free radical; Oxidative stress; Sirtuin; Superoxide anion (O 2 )

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FREE RADICAL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROBUCOL; RESVERATROL; SIRTUIN 1; SUCCINOBUCOL; SUPEROXIDE; SCAVENGER;

ANTIOXIDANT ACTIVITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; HUMAN; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; ANIMAL; CLINICAL TRIAL (TOPIC); METABOLISM; PHYSIOLOGY;

ANIMALS; ANTIOXIDANTS; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; CLINICAL TRIALS AS TOPIC; FREE RADICAL SCAVENGERS; FREE RADICALS; HUMANS; OXIDATIVE STRESS; PPAR GAMMA; RENIN-ANGIOTENSIN SYSTEM;

EID: 84860786577     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20110562     Document Type: Review

References (137)

1. Forstermann, U. (2008) Oxidative stress in vascular disease: causes, defense mechanisms and potential therapies. Nat. Clin. Pract. Cardiovasc. Med. 5, 338-349
2. Rahman, K. (2007) Studies on free radicals, antioxidants, and co-factors. Clin. Interv. Aging 2, 219-236
3. Rhee, S. G. (1999) Redox signaling: hydrogen peroxide as intracellular messenger. Exp. Mol. Med. 31, 53-59
4. Stamler, J. S. (1994) Redox signaling: nitrosylation and related target interactions of nitric oxide. Cell 78, 931-936
5. Ullrich, V. and Kissner, R. (2006) Redox signaling: bioinorganic chemistry at its best. J. Inorg. Biochem. 100, 2079-2086
6. Brandes, R. P. and Kreuzer, J. (2005) Vascular NADPH oxidases: molecular mechanisms of activation. Cardiovasc. Res. 65, 16-27
7. Rodriguez-Manas, L., El-Assar, M., Vallejo, S., López-Dóriga, P., Solís, J., Petidier, R., Montes, M., Nevado, J., Castro, M., Gómez-Guerrero, C. et al. (2009) Endothelial dysfunction in aged humans is related with oxidative stress and vascular inflammation. Aging Cell 8, 226-238
8. Golbidi, S. and Laher, I. (2010) Antioxidant therapy in human endocrine disorders. Med. Sci. Monit. 16, RA9-R24
9. Paravicini, T. M. and Touyz, R. M. (2008) NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities. Diabetes Care 2, S170-S180
10. Valko, M., Leibfritz, D., Moncol, J., Cronin, M. T., Mazur, M. and Telser, J. (2007) Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell. Biol. 39, 44-84
11. Touyz, R. M. (2004) Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance? Hypertension 44, 248-252
12. Folkow, B. and Svanborg, A. (1993) Physiology of cardiovascular aging. Physiol. Rev. 73, 725-764
13. Ungvari, Z., Kaley, G., de Cabo, R., Sonntag, W. E. and Csiszar, A. (2010) Mechanisms of vascular aging: new perspectives. J. Gerontol. A Biol. Sci. Med. Sci. 65, 1028-1041
14. Faraci, F.M (2010) Cerebral vascular dysfunction with aging. In Handbook of the Biology of Aging, 7th edn (Masoro, E. J and Austad, S. N., eds), pp. 405-419, Academic Press, New York
15. Chrissobolis, S. and Faraci, F. M. (2008) The role of oxidative stress and NADPH oxidase in cerebrovascular disease. Trends Mol. Med. 14, 495-502
16. Faraci, F. M. and Heistad, D. D. (1998) Regulation of the cerebral circulation: role of endothelium and potassium channels. Physiol. Rev. 78, 53-97
17. Chen, J., Zacharek, A., Zhang, C., Jiang, H., Li, Y., Roberts, C., Lu, M., Kapke, A. and Chopp, M. (2005) Endothelial nitric oxide synthase regulates brain-derived neurotrophic factor expression and neurogenesis after stroke in mice. J. Neurosci. 25, 2366-2375
18. Jagtap, P. and Szabo, C. (2005) Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors. Nat. Rev. Drug Discovery 4, 421-440
19. Modrick, M. L., Didion, S. P., Sigmund, C. D. and Faraci, F. M. (2009) Role of oxidative stress and AT1 receptors in cerebral vascular dysfunction with aging. Am. J. Physiol. Heart Circ. Physiol. 296, H1914-H1919
20. Park, L., Anrather, J., Girouard, H., Zhou, P. and Iadecola, C. (2007) Nox2-derived reactive oxygen species mediate neurovascular dysregulation in the aging mouse brain. J. Cereb. Blood Flow Metab. 27, 1908-1918
21. Benigni, A., Cassis, P. and Remuzzi, G. (2010) Angiotensin II revisited: new roles in inflammation, immunology and aging. EMBO Mol. Med. 2, 247-257
22. Wang, M., Takagi, G., Asai, K., Resuello, R. G., Natividad, F. F., Vatner, D. E., Vatner, S. F. and Lakatta, E. G. (2003) Aging increases aortic MMP-2 activity and angiotensin II in nonhuman primates. Hypertension 41, 1308-1316
23. Basso, N., Cini, R., Pietrelli, A., Ferder, L., Terragno, N. A. and Inserra, F. (2007) Protective effect of long-term angiotensin II inhibition. Am. J. Physiol. Heart Circ. Physiol. 293, H1351-H1358
24. Didion, S. P., Kinzenbaw, D. A., Schrader, L. I. and Faraci, F. M. (2006) Heterozygous CuZn superoxide dismutase deficiency produces a vascular phenotype with aging. Hypertension 48, 1072-1079
25. Brown, K. A., Didion, S. P., Andresen, J. J. and Faraci, F. M. (2007) Effect of aging, MnSOD deficiency, and genetic background on endothelial function: evidence for MnSOD haploinsufficiency. Arterioscler. Thromb. Vasc. Biol. 27, 1941-1946
26. Kuro-o, M. (2010) Klotho. Pflugers Arch. 459, 333-343
27. Rakugi, H., Matsukawa, N., Ishikawa, K., Yang, J., Imai, M., Ikushima, M., Maekawa, Y., Kida, I., Miyazaki, J. and Ogihara, T. (2007) Anti-oxidative effect of Klotho on endothelial cells through cAMP activation. Endocrine 31, 82-87
28. Wang, Y. and Sun, Z. (2009) Klotho gene delivery prevents the progression of spontaneous hypertension and renal damage. Hypertension 54, 810-817
29. Durrant, J. R., Seals, D. R., Connell, M. L., Russell, M. J., Lawson, B. R., Folian, B. J., Donato, A. J. and Lesniewski, L. A. (2009) Voluntary wheel running restores endothelial function in conduit arteries of old mice: direct evidence for reduced oxidative stress, increased superoxide dismutase activity and down-regulation of NADPH oxidase. J. Physiol. 587, 3271-3285
30. Rippe, C., Lesniewski, L., Connell, M., LaRocca, T., Donato, A. and Seals, D. (2010) Short-term calorie restriction reverses vascular endothelial dysfunction in old mice by increasing nitric oxide and reducing oxidative stress. Aging Cell 9, 304-312
31. Ketsawatsomkron, P., Pelham, C. J., Groh, S., Keen, H. L., Faraci, F. M. and Sigmund, C. D. (2010) Does peroxisome proliferator-activated receptor-γ (PPARγ) protect from hypertension directly through effects in the vasculature? J. Biol. Chem. 285, 9311-9316
32. Beyer, A. M., Baumbach, G. L., Halabi, C. M., Modrick, M. L., Lynch, C. M., Gerhold, T. D., Ghoneim, S. M., de Lange, W. J., Keen, H. L., Tsai, Y. S. et al. (2008) Interference with PPARγ signaling causes cerebral vascular dysfunction, hypertrophy, and remodeling. Hypertension 51, 867-871
33. Sung, B., Park, S., Yu, B. P. and Chung, H. Y. (2004) Modulation of PPAR in aging, inflammation, and calorie restriction. J. Gerontol. A Biol. Sci. Med. Sci. 59, 997-1006
34. Argmann, C., Dobrin, R., Heikkinen, S., Auburtin, A., Pouilly, L., Cock, T. A., Koutnikova, H., Zhu, J., Schadt, E. E., Auwerx, J. et al. (2009) Pparγ 2 is a key driver of longevity in the mouse. PLoS Genet. 5, e1000752
35. Zhang, H., Li, Y., Fan, Y., Wu, J., Zhao, B., Guan, Y., Chien, S. and Wang, N. (2008) Klotho is a target gene of PPAR-γ. Kidney Int. 74, 732-739
36. Nicolakakis, N., Aboulkassim, T., Ongali, B., Lecrux, C., Fernandes, P., Rosa-Neto, P., Tong, X. K. and Hamel, E. (2008) Complete rescue of cerebrovascular function in aged Alzheimer's disease transgenic mice by antioxidants and pioglitazone, a peroxisome proliferator-activated receptor γ agonist. J. Neurosci. 28, 9287-9296
37. Heitzer, T., Schlinzig, T., Krohn, K., Meinertz, T. and Munzel, T. (2001) Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 104, 2673-2678
38. Doerries, C., Grote, K., Hilfiker-Kleiner, D., Luchtefeld, M., Schaefer, A., Holland, S. M., Sorrentino, S., Manes, C., Schieffer, B., Drexler, H. and Landmesser, U. (2007) Critical role of the NAD(P)H oxidase subunit p47phox for left ventricular remodeling/dysfunction and survival after myocardial infarction. Circ. Res. 100, 894-903
39. Wenzel, P., Schuhmacher, S., Kienhofer, J., M̈ uller, J., Hortmann, M., Oelze, M., Schulz, E., Treiber, N., Kawamoto, T., Scharffetter-Kochanek, K. et al. (2008) Manganese superoxide dismutase and aldehyde dehydrogenase deficiency increase mitochondrial oxidative stress and aggravate age-dependent vascular dysfunction. Cardiovasc. Res. 80, 280-289
40. Heart Protection Study Collaborative Group MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial (2002) Lancet 360, 7-22
41. The Coronary Drug Project Group (1975) Clofibrate and niacin in coronary heart disease. JAMA, J. Am. Med. Assoc. 231, 360-381
42. Rubins, H. B., Robins, S. J., Collins, D., Fye, C. L., Anderson, J.W., Elam, M. B., Faas, F. H., Linares, E., Schaefer, E. J., Schectman, G. et al. (1999) Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. N. Engl. J. Med. 341, 410-418
43. GISSI-Prevenzione Investigators (1999) Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial Lancet 354, 447-455
44. de Lorgeril, M., Salen, P., Martin, J. L., Monjaud, I., Delaye, J. and Mamelle, N. (1999) Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation. 99, 779-785
45. Touyz, R. M. and Schiffrin, E. L. (2004) Reactive oxygen species in vascular biology: implications in hypertension. Histochem. Cell Biol. 122, 339-352
46. Vivekananthan, D. P., Penn, M. S., Sapp, S. K., Hsu, A. and Topol, E. J. (2003) Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials. Lancet 361, 2017-2023
47. Sawayama, Y., Shimizu, C., Maeda, N., Tatsukawa, M., Kinukawa, N., Koyanagi, S., Kashiwagi, S. and Hayashi, J. (2002) Effects of probucol and pravastatin on common carotid atherosclerosis in patients with asymptomatic hypercholesterolemia. Fukuoka Atherosclerosis Trial (FAST). J. Am. Coll. Cardiol. 39, 610-616
48. oadell, K., Johansson, J., Kaijser, L., Lassvik, C., Mölgaard, J., Nilsson, S. et al. (1994) The effect of probucol on femoral atherosclerosis: the Probucol Quantitative Regression Swedish Trial (PQRST). Am. J. Cardiol. 74, 875-883
49. Tardif, J. C., McMurray, J. J., Klug, E., Small, R., Schumi, J., Choi, J., Cooper, J., Scott, R., Lewis, E. F., L'Allier, P. L. and Pfeffer, M. A. (2008) Effects of succinobucol (AGI-1067) after an acute coronary syndrome: a randomised, double-blind, placebo-controlled trial. Lancet 371, 1761-1768
50. Heart Protection Study Collaborative Group MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20536 high-risk individuals: a randomised placebo-controlled trial (2002) Lancet 360, 23-33
51. Rembold, C. M. (2007) To statin or to non-statin in coronary disease - considering absolute risk is the answer. Atherosclerosis 195, 1-6
52. Roberts, II, L. J., Oates, J. A., Linton, M. F., Fazio, S., Meador, B. P., Gross, M. D., Shyr, Y. and Morrow, J. D. (2007) The relationship between dose of vitamin E and suppression of oxidative stress in humans. Free Radical Biol. Med. 43, 1388-1393
53. Collins, A. R., Lyon, C. J., Xia, X., Liu, J. Z., Tangirala, R. K., Yin, F., Boyadjian, R., Bikineyeva, A., Pratic ' o, D., Harrison, D. G. and Hsueh, W. A. (2009) Ageaccelerated atherosclerosis correlates with failure to upregulate antioxidant genes. Circ. Res. 104, e42-e54
54. Sofi, F., Conti, A. A., Gori, A. M., Eliana Luisi, M. L., Casini, A., Abbate, R. and Gensini, G. F. (2007) Coffee consumption and risk of coronary heart disease: a meta-analysis. Nutr.Metab. Cardiovasc. Dis. 17, 209-223
55. Santos, C., Costa, J., Santos, J., Vaz-Carneiro, A. and Lunet, N. (2010) Caffeine intake and dementia: systematic review and meta-analysis. J. Alzheimers Dis. 20, S187-S204
56. Lee, D. H., Folsom, A. R., Harnack, L., Halliwell, B. and Jacobs, D.R.J. (2004) Does supplemental vitamin C increase cardiovascular disease risk in women with diabetes? Am. J. Clin. Nutr. 80, 1194-1200
57. Elhaimeur, F., Courderot-Masuyer, C., Nicod, L., Guyon, C., Richert, L. and Berthelot, A. (2002) Dietary vitamin C supplementation decreases blood pressure in DOCA-salt hypertensive male Sprague-Dawley rats and this is associated with increased liver oxidative stress. Mol. Cell. Biochem. 237, 77-83
58. Heitzer, T., Just, H. and Munzel, T. (1996) Antioxidant vitamin C improves endothelial dysfunction in chronic smokers. Circulation 94, 6-9
59. Daiber, A. and Ullrich, V. (2002) Radikalchemie im Organismus: Stickstoffmonoxid, Superoxid und Peroxynitrit. Chem. Unserer Zeit 36, 366-375
60. Daiber, A. and Bachschmid, M. (2007) Enzyme inhibition by peroxynitrite-mediated tyrosine nitration and thiol oxidation. Curr. Enzyme Inhib. 3, 103-117
61. Wendel, A., Fausel, M., Safayhi, H., Tiegs, G. and Otter, R. (1984) A novel biologically active seleno-organic compound-II. Activity of PZ 51 in relation to glutathione peroxidase. Biochem. Pharmacol. 33, 3241-3245
62. Daiber, A., Zou, M. H., Bachschmid, M. and Ullrich, V. (2000) Ebselen as a peroxynitrite scavenger in vitro and ex vivo. Biochem. Pharmacol. 59, 153-160
63. Pasternack, R. F. and Skowronek, W.R.J. (1979) Catalysis of the disproportionation of superoxide by metalloporphyrins. J. Inorg. Biochem. 11, 261-267
64. Misko, T. P., Highkin, M. K., Veenhuizen, A.W., Manning, P. T., Stern, M. K., Currie, M. G. and Salvemini, D. (1998) Characterization of the cytoprotective action of peroxynitrite decomposition catalysts. J. Biol. Chem. 273, 15646-15653
65. Suzuki, H., DeLano, F. A., Parks, D. A., Jamshidi, N., Granger, D. N., Ishii, H., Suematsu, M., Zweifach, B. W. and Schmid-Schönbein, G.W. (1998) Xanthine oxidase activity associated with arterial blood pressure in spontaneously hypertensive rats. Proc. Natl. Acad. Sci. U.S.A. 95, 4754-4759
66. Butler, R., Morris, A. D., Belch, J. J., Hill, A. and Struthers, A. D. (2000) Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension. Hypertension 35, 746-751
67. Lee, B. E., Toledo, A. H., Anaya-Prado, R., Roach, R. R. and Toledo-Pereyra, L. H. (2009) Allopurinol, xanthine oxidase, and cardiac ischemia. J. Investig. Med. 57, 902-909
68. Griendling, K. K. and FitzGerald, G. A. (2003) Oxidative stress and cardiovascular injury: part I: basic mechanisms and in vivo monitoring of ROS. Circulation 108, 1912-1916
69. Heumuller, S., Wind, S., Barbosa-Sicard, E., Schmidt, H. H., Busse, R., Schröder, K. and Brandes, R. P. (2008) Apocynin is not an inhibitor of vascular NADPH oxidases but an antioxidant. Hypertension 51, 211-217
70. Jaquet, V., Scapozza, L., Clark, R. A., Krause, K. H. and Lambeth, J. D. (2009) Small-molecule NOX inhibitors: ROS-generating NADPH oxidases as therapeutic targets. Antioxid. Redox Signaling 11, 2535-2552
71. Brandes, R. P. and Schroder, K. (2008) Differential vascular functions of Nox family NADPH oxidases. Curr. Opin. Lipidol. 19, 513-518
72. Munzel, T., Daiber, A., Ullrich, V. and Mulsch, A. (2005) Vascular consequences of endothelial nitric oxide synthase uncoupling for the activity and expression of the soluble guanylyl cyclase and the cGMP-dependent protein kinase. Arterioscler. Thromb. Vasc. Biol. 25, 1551-1557
73. Schulz, E., Jansen, T., Wenzel, P., Daiber, A. and Munzel, T. (2008) Nitric oxide, tetrahydrobiopterin, oxidative stress, and endothelial dysfunction in hypertension. Antioxid. Redox Signaling 10, 1115-1126
74. Alp, N. J., Mussa, S., Khoo, J., Cai, S., Guzik, T., Jefferson, A., Goh, N., Rockett, K. A. and Channon, K. M. (2003) Tetrahydrobiopterin-dependent preservation of nitric oxide-mediated endothelial function in diabetes by targeted transgenic GTP-cyclohydrolase I overexpression. J. Clin. Invest. 112, 725-735
75. Schnabel, R., Blankenberg, S., Lubos, E., Lackner, K. J., Rupprecht, H. J., Espinola-Klein, C., Jachmann, N., Post, F., Peetz, D., Bickel, C. et al. (2005) Asymmetric dimethylarginine and the risk of cardiovascular events and death in patients with coronary artery disease: results from the AtheroGene Study. Circ. Res. 97, e53-e59
76. Li, H. and Forstermann, U. (2009) Prevention of atherosclerosis by interference with the vascular nitric oxide system. Curr. Pharm. Des. 15, 3133-3145
77. Li, Y., Huang, T. T., Carlson, E. J., Melov, S., Ursell, P. C., Olson, J. L., Noble, L. J., Yoshimura, M. P., Berger, C., Chan, P. H. et al. (1995) Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat. Genet. 11, 376-381
78. Jung, O., Marklund, S. L., Geiger, H., Pedrazzini, T., Busse, R. and Brandes, R. P. (2003) Extracellular superoxide dismutase is a major determinant of nitric oxide bioavailability: in vivo and ex vivo evidence from ecSOD-deficient mice. Circ. Res. 93, 622-629
79. Daiber, A. (2010) Redox signaling (cross-talk) from and to mitochondria involves mitochondrial pores and reactive oxygen species. Biochim. Biophys. Acta 1797, 897-906
80. Di Lisa, F. and Bernardi, P. (2006) Mitochondria and ischemia-reperfusion injury of the heart: fixing a hole. Cardiovasc. Res. 70, 191-199
81. Piot, C., Croisille, P., Staat, P., Thibault, H., Rioufol, G., Mewton, N., Elbelghiti, R., Cung, T. T., Bonnefoy, E., Angoulvant, D. et al. (2008) Effect of cyclosporine on reperfusion injury in acute myocardial infarction. N. Engl. J. Med. 359, 473-481
82. Koopman, W. J., Verkaart, S., Visch, H. J., van der Westhuizen, F. H., Murphy, M. P., van den Heuvel, L. W., Smeitink, J. A. and Willems, P. H. (2005) Inhibition of complex I of the electron transport chain causes O2 - -mediated mitochondrial outgrowth. Am. J. Physiol. Cell Physiol. 288, C1440-C1450
83. Wenzel, P., Mollnau, H., Oelze, M., Schulz, E., Wickramanayake, J. M., Müller, J., Schuhmacher, S., Hortmann, M., Baldus, S., Gori, T. et al. (2008) First evidence for a crosstalk between mitochondrial and NADPH oxidase-derived reactive oxygen species in nitroglycerin-triggered vascular dysfunction. Antioxid. Redox Signaling 10, 1435-1447
84. Daiber, A., Oelze, M., Sulyok, S., Coldewey, M., Schulz, E., Treiber, N., Hink, U., Mülsch, A., Scharffetter-Kochanek, K. and Münzel, T. (2005) Heterozygous deficiency of manganese superoxide dismutase in mice (Mn-SOD+ /-): a novel approach to assess the role of oxidative stress for the development of nitrate tolerance. Mol. Pharmacol. 68, 579-588
85. Esplugues, J. V., Rocha, M., Nunez, C., Bosca, I., Ibiza, S., Herance, J. R., Ortega, A., Serrador, J. M., D'Ocon, P. and Victor, V. M. (2006) Complex I dysfunction and tolerance to nitroglycerin: an approach based on mitochondrial-targeted antioxidants. Circ. Res. 99, 1067-1075
86. Dikalova, A. E., Bikineyeva, A. T., Budzyn, K., Budzyn, K., Nazarewicz, R. R., McCann, L., Lewis, W., Harrison, D. G. and Dikalov, S. I. (2010) Therapeutic targeting of mitochondrial superoxide in hypertension. Circ. Res. 107, 106-116
87. Fukai, T., Folz, R. J., Landmesser, U. and Harrison, D. G. (2002) Extracellular superoxide dismutase and cardiovascular disease. Cardiovasc. Res. 55, 239-249
88. Shuvaev, V. V., Christofidou-Solomidou, M., Bhora, F., Laude, K., Cai, H., Dikalov, S., Arguiri, E., Solomides, C. C., Albelda, S. M., Harrison, D. G. and Muzykantov, V. R. (2009) Targeted detoxification of selected reactive oxygen species in the vascular endothelium. J. Pharmacol. Exp. Ther. 331, 404-411
89. Fernandez, C., Hattan, C. M. and Kerns, R. J. (2006) Semi-synthetic heparin derivatives: chemical modifications of heparin beyond chain length, sulfate substitution pattern and N-sulfo/N-acetyl groups. Carbohydr. Res. 341, 1253-1265
90. Taylor, A. L., Ziesche, S., Yancy, C., Carson, P., D'Agostino, Jr, R., Ferdinand, K., Taylor, M., Adams, K., Sabolinski, M., Worcel, M. and Cohn, J. N. (2004) Combination of isosorbide dinitrate and hydralazine in blacks with heart failure.N. Engl. J. Med. 351, 2049-2057
91. Daiber, A., Oelze, M., Coldewey, M., Huth, C., Schildknecht, S., Bachschmid, M., Nazirisadeh, Y., Ullrich, V., Mülsch, A., Münzel, T. and Tsilimingas, N. (2005) Hydralazine is a powerful inhibitor of peroxynitrite formation as a possible explanation for its beneficial effects on prognosis in patients with congestive heart failure. Biochem. Biophys. Res. Commun. 338, 1865-1874
92. Munzel, T., Kurz, S., Rajagopalan, S., Thoenes, M., Berrington, W. R., Thompson, J. A., Freeman, B. A. and Harrison, D. G. (1996) Hydralazine prevents nitroglycerin tolerance by inhibiting activation of a membrane-bound NADH oxidase. A new action for an old drug. J. Clin. Invest. 98, 1465-1470
93. Thomas, G. R., DiFabio, J. M., Gori, T. and Parker, J. D. (2007) Once daily therapy with isosorbide-5-mononitrate causes endothelial dysfunction in humans: evidence of a free-radical-mediated mechanism. J. Am. Coll. Cardiol. 49, 1289-1295
94. Munzel, T., Daiber, A. and Mulsch, A. (2005) Explaining the phenomenon of nitrate tolerance. Circ. Res. 97, 618-628
95. Schuhmacher, S., Wenzel, P., Schulz, E., Oelze, M., Mang, C., Kamuf, J., Gori, T., Jansen, T., Knorr, M., Karbach, S. et al. (2010) Pentaerythritol tetranitrate improves angiotensin II-induced vascular dysfunction via induction of heme oxygenase-1. Hypertension 55, 897-904
96. Oppermann, M., Balz, V., Adams, V., Dao, V. T., Bas, M., Suvorava, T. and Kojda, G. (2009) Pharmacological induction of vascular extracellular superoxide dismutase expression in vivo. J. Cell. Mol. Med. 13, 1271-1278
97. Pautz, A., Rauschkolb, P., Schmidt, N., Art, J., Oelze, M., Wenzel, P., Förstermann, U., Daiber, A. and Kleinert, H. (2009) Effects of nitroglycerin or pentaerithrityl tetranitrate treatment on the gene expression in rat hearts: evidence for cardiotoxic and cardioprotective effects. Physiol. Genomics. 38, 176-185
98. Gori, T. and Daiber, A. (2009) Non-hemodynamic effects of organic nitrates and the distinctive characteristics of pentaerithrityl tetranitrate. Am. J. Cardiovasc. Drugs 9, 7-15
99. Schuhmacher, S., Oelze, M., Bollmann, F., Kleinert, H., Otto, C., Heeren, T., Steven, S., Hausding, M., Knorr, M., Pautz, A. et al. (2011) Vascular dysfunction in experimental diabetes is improved by pentaerithrityl tetranitrate but not isosorbide-5-mononitrate therapy. Diabetes 60, 2608-2616
100. Asahara, T., Murohara, T., Sullivan, A., Silver, M., van der Zee, R., Li, T., Witzenbichler, B., Schatteman, G. and Isner, J. M. (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275, 964-967
101. Rehman, J., Li, J., Orschell, C. M. and March, K. L. (2003) Peripheral blood 'endothelial progenitor cells' are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 107, 1164-1169
102. Fadini, G. P. and Avogaro, A. (2010) Potential manipulation of endothelial progenitor cells in diabetes and its complications. Diabetes Obes. Metab. 12, 570-583
103. Jarajapu, Y. P. and Grant, M. B. (2010) The promise of cell-based therapies for diabetic complications: challenges and solutions. Circ. Res. 106, 854-869
104. Tepper, O. M., Galiano, R. D., Capla, J. M., Kalka, C., Gagne, P. J., Jacobowitz, G. R., Levine, J. P. and Gurtner, G. C. (2002) Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 106, 2781-2786
105. Penn, M. S. and Topol, E. J. (2001) Tissue factor, the emerging link between inflammation, thrombosis, and vascular remodeling. Circ. Res. 89, 1-2
106. Scheubel, R. J., Zorn, H., Silber, R. E., Kuss, O., Morawietz, H., Holtz, J. and Simm, A. (2003) Age-dependent depression in circulating endothelial progenitor cells in patients undergoing coronary artery bypass grafting. J. Am. Coll. Cardiol. 42, 2073-2080
107. Tepper, O. M., Galiano, R. D., Capla, J. M., Kalka, C., Gagne, P. J., Jacobowitz, G. R., Levine, J. P. and Gurtner, G. C. (2002) Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 106, 2781-2786
108. Imanishi, T., Moriwaki, C., Hano, T. and Nishio, I. (2005) Endothelial progenitor cell senescence is accelerated in both experimental hypertensive rats and patients with essential hypertension. J. Hypertens. 23, 1831-1837
109. Chen, D. D. and Chen, A. F. (2006) CuZn superoxide dismutase deficiency: culprit of accelerated vascular aging process. Hypertension 48, 1026-1028
110. Keswani, S. G., Katz, A. B., Lim, F. Y., Zoltick, P., Radu, A., Alaee, D., Herlyn, M. and Crombleholme, T. M. (2004) Adenoviral mediated gene transfer of PDGF-B enhances wound healing in type I and type II diabetic wounds. Wound Repair Regen. 12, 497-504
111. Imanishi, T., Kobayashi, K., Hano, T. and Nishio, I. (2005) Effect of estrogen on differentiation and senescence in endothelial progenitor cells derived from bone marrow in spontaneously hypertensive rats. Hypertens Res. 28, 763-772
112. Asai, J., Takenaka, H., Kusano, K. F., Ii, M., Luedemann, C., Curry, C., Eaton, E., Iwakura, A., Tsutsumi, Y., Hamada, H. et al. (2006) Topical sonic hedgehog gene therapy accelerates wound healing in diabetes by enhancing endothelial progenitor cell-mediated microvascular remodeling. Circulation 113, 2413-2424
113. Thum, T., Fraccarollo, D., Schultheiss, M., Froese, S., Galuppo, P., Widder, J. D., Tsikas, D., Ertl, G. and Bauersachs, J. (2007) Endothelial nitric oxide synthase uncoupling impairs endothelial progenitor cell mobilization and function in diabetes. Diabetes 56, 666-674
114. Xie, H. H., Zhou, S., Chen, D. D., Channon, K. M., Su, D. F. and Chen, A. F. (2010) GTP cyclohydrolase I/BH4 pathway protects EPCs via suppressing oxidative stress and thrombospondin-1 in salt-sensitive hypertension. Hypertension 56, 1137-1144
115. Wang, X. R., Zhang, M. W., Chen, D. D., Zhang, Y. and Chen, A. F. (2011) AMP-activated protein kinase rescues the angiogenic functions of endothelial progenitor cells via manganese superoxide dismutase induction in type 1 diabetes. Am. J. Physiol. Endocrinol. Metab. 300, E1135-E1145
116. Di Stefano, V., Cencioni, C., Zaccagnini, G., Magenta, A., Capogrossi, M. C. and Martelli, F. (2009) p66ShcA modulates oxidative stress and survival of endothelial progenitor cells in response to high glucose. Cardiovasc. Res. 82, 421-429
117. He, T., Joyner, M. J. and Katusic, Z. S. (2009) Aging decreases expression and activity of glutathione peroxidase-1 in human endothelial progenitor cells. Microvasc. Res. 78, 447-452
118. Fujii, H., Li, S. H., Szmitko, P. E., Fedak, P.W. and Verma, S. (2006) C-reactive protein alters antioxidant defenses and promotes apoptosis in endothelial progenitor cells. Arterioscler. Thromb. Vasc. Biol. 26, 2476-2482
119. Laufs, U., Werner, N., Link, A., Endres, M., Wassmann, S., Jürgens, K., Miche, E., Böhm, M. and Nickenig, G. (2004) Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis. Circulation 109, 220-226
120. Werner, C., Kamani, C. H., Gensch, C., Bohm, M. and Laufs, U. (2007) The peroxisome proliferator-activated receptor-γ agonist pioglitazone increases number and function of endothelial progenitor cells in patients with coronary artery disease and normal glucose tolerance. Diabetes 56, 2609-2615
121. Togliatto, G., Trombetta, A., Dentelli, P., Baragli, A., Rosso, A., Granata, R., Ghigo, D., Pegoraro, L., Ghigo, E. and Brizzi, M. F. (2010) Unacylated ghrelin rescues endothelial progenitor cell function in individuals with type 2 diabetes. Diabetes 59, 1016-1025
122. Marrotte, E. J., Chen, D. D., Hakim, J. S. and Chen, A. F. (2010) Manganese superoxide dismutase expression in endothelial progenitor cells accelerates wound healing in diabetic mice. J. Clin. Invest. 120, 4207-4219
123. Murasawa, S., Llevadot, J., Silver, M., Isner, J. M., Losordo, D. W. and Asahara, T. (2002) Constitutive human telomerase reverse transcriptase expression enhances regenerative properties of endothelial progenitor cells. Circulation 106, 1133-1139
124. Sasaki, K., Heeschen, C., Aicher, A., Ziebart, T., Honold, J., Urbich, C., Rossig, L., Koehl, U., Koyanagi, M., Mohamed, A. et al. (2006) Ex vivo pretreatment of bone marrow mononuclear cells with endothelial NO synthase enhancer AVE9488 enhances their functional activity for cell therapy. Proc. Natl. Acad. Sci. U.S.A. 103, 14537-14541
125. Zhao, T., Li, J. and Chen, A. F. (2010) MicroRNA-34a induces endothelial progenitor cell senescence and impedes its angiogenesis via suppressing silent information regulator 1. (2010) Am. J. Physiol. Endocrinol. Metab. 299, E110-E116
126. Milne, J. C. and Denu, J. M. (2008) The Sirtuin family: therapeutic targets to treat diseases of aging. Curr. Opin. Chem. Biol. 12, 11-17
127. Michan, S. and Sinclair, D. (2007) Sirtuins in mammals: insights into their biological function. Biochem. J. 404, 1-13
128. Pfluger, P. T., Herranz, D., Velasco-Miguel, S., Serrano, M. and Tschop, M. H. (2008) Sirt1 protects against high-fat diet-induced metabolic damage. Proc. Natl. Acad. Sci. U.S.A. 105, 9793-9798
129. Cardellini, M., Menghini, R., Martelli, E., Casagrande, V., Marino, A., Rizza, S., Porzio, O., Mauriello, A., Solini, A., Ippoliti, A. et al. (2009) TIMP3 is reduced in atherosclerotic plaques from subjects with type 2 diabetes and increased by SirT1. Diabetes 58, 2396-2401
130. Miyazaki, R., Ichiki, T., Hashimoto, T., Inanaga, K., Imayama, I., Sadoshima, J. and Sunagawa, K. (2008) SIRT1, a longevity gene, downregulates angiotensin II type 1 receptor expression in vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 28, 1263-1269
131. Zhang, Q. J., Wang, Z., Chen, H. Z., Zhou, S., Zheng, W., Liu, G., Wei, Y. S., Cai, H., Liu, D. P. and Liang, C. C. (2008) Endothelium-specific overexpression of class III deacetylase SIRT1 decreases atherosclerosis in apolipoprotein E-deficient mice. (2008) Cardiovasc. Res. 80, 191-199
132. Alcendor, R. R., Gao, S., Zhai, P., Zablocki, D., Holle, E., Yu, X., Tian, B., Wagner, T., Vatner, S. F. and Sadoshima, J. (2007) Sirt1 regulates aging and resistance to oxidative stress in the heart. Circ. Res. 100, 1512-1521
133. Li, H., Wallerath, T., Munzel, T. and Forstermann, U. (2002) Regulation of endothelial-type NO synthase expression in pathophysiology and in response to drugs. Nitric Oxide 7, 149-164
134. Alp, N. J., McAteer, M. A., Khoo, J., Choudhury, R. P. and Channon, K. M. (2004) Increased endothelial tetrahydrobiopterin synthesis by targeted transgenic GTP-cyclohydrolase I overexpression reduces endothelial dysfunction and atherosclerosis in ApoE-knockout mice. Arterioscler. Thromb. Vasc. Biol. 24, 445-450
135. Xia, N., Daiber, A., Habermeier, A., Closs, E. I., Thum, T., Spanier, G., Lu, Q., Oelze, M., Torzewski, M., Lackner, K. J. et al. (2010) Resveratrol reverses endothelial nitric-oxide synthase uncoupling in apolipoprotein E knockout mice. J. Pharmacol. Exp. Ther. 335, 149-154
136. Xu, H., Goettsch, C., Xia, N., Horke, S., Morawietz, H., Förstermann, U. and Li, H. (2008) Differential roles of PKCα and PKCε in controlling the gene expression of Nox4 in human endothelial cells. Free Radical Biol.Med. 44, 1656-1667
137. Tanno, M., Kuno, A., Yano, T., Miura, T., Hisahara, S., Ishikawa, S., Shimamoto, K. and Horio, Y. (2010) Induction of manganese superoxide dismutase by nuclear translocation and activation of SIRT1 promotes cell survival in chronic heart failure. J. Biol. Chem. 285, 8375-8382